Southern Research collaborating to develop coronavirus vaccine

Birmingham-based Southern Research has entered into a strategic collaboration with New York-based clinical-stage biopharmaceutical company Tonix Pharmaceuticals to support the development of a vaccine against the new coronavirus disease, COVID-19.   The vaccine is based on Tonix’s proprietary horsepox vaccine platform, TNX-801. The vaccine has been developed as a potential smallpox preventing vaccine for the U.S. strategic national stockpile and as a vaccine against monkeypox. According to Southern…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news